Cargando…
The Challenge and Management of Clinical Trials in Integrative Cancer during the COVID-19 Pandemic Worldwide
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869149/ https://www.ncbi.nlm.nih.gov/pubmed/33543656 http://dx.doi.org/10.1177/1534735421991218 |
| _version_ | 1783648570617888768 |
|---|---|
| author | Yang, Geliang Li, Min Zhang, Huiqing Yang, Yufei |
| author_facet | Yang, Geliang Li, Min Zhang, Huiqing Yang, Yufei |
| author_sort | Yang, Geliang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7869149 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | SAGE Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78691492021-02-19 The Challenge and Management of Clinical Trials in Integrative Cancer during the COVID-19 Pandemic Worldwide Yang, Geliang Li, Min Zhang, Huiqing Yang, Yufei Integr Cancer Ther Letter to the Editor SAGE Publications 2021-02-05 /pmc/articles/PMC7869149/ /pubmed/33543656 http://dx.doi.org/10.1177/1534735421991218 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
| spellingShingle | Letter to the Editor Yang, Geliang Li, Min Zhang, Huiqing Yang, Yufei The Challenge and Management of Clinical Trials in Integrative Cancer during the COVID-19 Pandemic Worldwide |
| title | The Challenge and Management of Clinical Trials in Integrative Cancer during
the COVID-19 Pandemic Worldwide |
| title_full | The Challenge and Management of Clinical Trials in Integrative Cancer during
the COVID-19 Pandemic Worldwide |
| title_fullStr | The Challenge and Management of Clinical Trials in Integrative Cancer during
the COVID-19 Pandemic Worldwide |
| title_full_unstemmed | The Challenge and Management of Clinical Trials in Integrative Cancer during
the COVID-19 Pandemic Worldwide |
| title_short | The Challenge and Management of Clinical Trials in Integrative Cancer during
the COVID-19 Pandemic Worldwide |
| title_sort | challenge and management of clinical trials in integrative cancer during
the covid-19 pandemic worldwide |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869149/ https://www.ncbi.nlm.nih.gov/pubmed/33543656 http://dx.doi.org/10.1177/1534735421991218 |
| work_keys_str_mv | AT yanggeliang thechallengeandmanagementofclinicaltrialsinintegrativecancerduringthecovid19pandemicworldwide AT limin thechallengeandmanagementofclinicaltrialsinintegrativecancerduringthecovid19pandemicworldwide AT zhanghuiqing thechallengeandmanagementofclinicaltrialsinintegrativecancerduringthecovid19pandemicworldwide AT yangyufei thechallengeandmanagementofclinicaltrialsinintegrativecancerduringthecovid19pandemicworldwide AT yanggeliang challengeandmanagementofclinicaltrialsinintegrativecancerduringthecovid19pandemicworldwide AT limin challengeandmanagementofclinicaltrialsinintegrativecancerduringthecovid19pandemicworldwide AT zhanghuiqing challengeandmanagementofclinicaltrialsinintegrativecancerduringthecovid19pandemicworldwide AT yangyufei challengeandmanagementofclinicaltrialsinintegrativecancerduringthecovid19pandemicworldwide |